| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.4B | $2.0B | $1.6B | $1.5B | $1.6B | $1.3B | $2.6B | $2.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.2B | $0.3B | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $4.4B | $3.4B | $2.8B | $1.8B | $1.6B | $1.2B | $1.1B | $1.1B |
| EPS (Basic) | $2.23 | $6.99 | $5.72 | $3.78 | $3.27 | $2.44 | $2.11 | $2.30 |
| EPS (Diluted) | $2.22 | $6.93 | $5.67 | $3.75 | $3.24 | $2.42 | $2.10 | $2.28 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $203.2B | $150.1B | $128.4B | $115.1B | $109.1B | $95.7B | $71.7B | $60.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $5.0B | $3.6B | $3.8B | $3.4B | $2.4B | $4.3B | $2.9B | $2.6B |
| Total Liabilities | $182.8B | $133.5B | $114.4B | $103.5B | $98.9B | $86.7B | $63.7B | $53.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $5.4B | $4.3B | $3.6B | $2.8B | $2.4B | $2.0B | $1.5B | $1.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $15.8B | $8.7B | $4.5B | $4.0B | $5.9B | $8.1B | $2.7B | $2.4B |
| Investing Cash Flow | $-0.2B | $-0.0B | $-0.1B | $-0.1B | $-0.2B | $-0.1B | $-0.1B | $-0.1B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.0B | $-0.8B | $-0.6B | $-0.5B | $-0.5B | $-0.2B | $-0.4B | $-0.4B |